Business
Press Release Feb 24 2023
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 24, 2023, titled "Zydus receivesfinal approval from the USFDA for Pitavastatin Tablets, 1 mg, 2 mg, and 4 mg".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 24, 2023, titled \"Zydus receivesfinal approval from the USFDA for Pitavastatin Tablets, 1 mg, 2 mg, and 4 mg\". View Attachment","length":358,"tagName":"div"}]